These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32300761)

  • 1. High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease.
    Sahoo BR; Cox SJ; Ramamoorthy A
    Chem Commun (Camb); 2020 Apr; 56(34):4627-4639. PubMed ID: 32300761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification.
    Kotler SA; Brender JR; Vivekanandan S; Suzuki Y; Yamamoto K; Monette M; Krishnamoorthy J; Walsh P; Cauble M; Holl MM; Marsh EN; Ramamoorthy A
    Sci Rep; 2015 Jul; 5():11811. PubMed ID: 26138908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
    König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
    J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation Mechanisms and Molecular Structures of Amyloid-β in Alzheimer's Disease.
    Niu Z; Gui X; Feng S; Reif B
    Chemistry; 2024 Aug; 30(48):e202400277. PubMed ID: 38888453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular structure of Alzheimer β-amyloid fibrils formed in the presence of phospholipid vesicles.
    Niu Z; Zhao W; Zhang Z; Xiao F; Tang X; Yang J
    Angew Chem Int Ed Engl; 2014 Aug; 53(35):9294-7. PubMed ID: 24810551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.
    Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules.
    Wärmländer S; Tiiman A; Abelein A; Luo J; Jarvet J; Söderberg KL; Danielsson J; Gräslund A
    Chembiochem; 2013 Sep; 14(14):1692-704. PubMed ID: 23983094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Stable Amyloid-β Oligomers Without Perturbative Methods.
    Kotler SA; Ramamoorthy A
    Methods Mol Biol; 2018; 1777():331-338. PubMed ID: 29744846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
    Kreutzer AG; Nowick JS
    Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-State Structure of Abeta (Aβ) in Alzheimer's Disease.
    Lu JX; Dong XQ; Zhang JJ
    Protein Pept Lett; 2017; 24(4):322-330. PubMed ID: 28183246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of amyloid-β aggregation in Alzheimer's disease.
    Wang Q; Yu X; Li L; Zheng J
    Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation kinetics and structural features of Beta-amyloid aggregates by sedimented solute NMR.
    Bertini I; Gallo G; Korsak M; Luchinat C; Mao J; Ravera E
    Chembiochem; 2013 Sep; 14(14):1891-7. PubMed ID: 23821412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alzheimer's amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization.
    Tay WM; Huang D; Rosenberry TL; Paravastu AK
    J Mol Biol; 2013 Jul; 425(14):2494-508. PubMed ID: 23583777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers.
    Lopez del Amo JM; Fink U; Dasari M; Grelle G; Wanker EE; Bieschke J; Reif B
    J Mol Biol; 2012 Aug; 421(4-5):517-24. PubMed ID: 22300765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hexameric peptide barrel as building block of amyloid-β protofibrils.
    Lendel C; Bjerring M; Dubnovitsky A; Kelly RT; Filippov A; Antzutkin ON; Nielsen NC; Härd T
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12756-60. PubMed ID: 25256598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease.
    Brody DL; Jiang H; Wildburger N; Esparza TJ
    Alzheimers Res Ther; 2017 Aug; 9(1):62. PubMed ID: 28818091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.